v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Total
Series A Convertible Preferred Stock
Common stock
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2024   0 8,700,386      
Beginning balance at Dec. 31, 2024 $ (6,012,089) $ 0 $ 870 $ 169,705,480 $ (428,809) $ (175,289,630)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation 377,357     377,357    
Issuance of common stock, net of issuance costs (in shares)     150,000      
Issuance of common stock, net of issuance costs 436,248   $ 15 436,233    
Net loss (4,378,307)         (4,378,307)
Foreign currency translation adjustments 13,090       13,090  
Ending balance (in shares) at Mar. 31, 2025   0 8,850,386      
Ending balance at Mar. 31, 2025 $ (9,563,701) $ 0 $ 885 170,519,070 (415,719) (179,667,937)
Beginning balance (in shares) at Dec. 31, 2025 14,499,502 0 14,499,502      
Beginning balance at Dec. 31, 2025 $ 2,842,634 $ 0 $ 1,450 191,951,711 (421,623) (188,688,904)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock-based compensation 455,064     455,064    
Issuance of Series A Convertible Preferred Stock and warrants in connection with Regulation A financing, net of issuance costs (in shares)   65,640        
Issuance of Series A Convertible Preferred Stock and warrants in connection with Regulation A financing, net of issuance costs 297,213 $ 656   296,557    
Issuance of common stock, net of issuance costs (in shares)     60,000      
Issuance of common stock, net of issuance costs 94,887   $ 6 94,881    
Net loss (2,999,889)         (2,999,889)
Foreign currency translation adjustments $ 44,542       44,542  
Ending balance (in shares) at Mar. 31, 2026 14,559,502 65,640 14,559,502      
Ending balance at Mar. 31, 2026 $ 734,451 $ 656 $ 1,456 $ 192,798,213 $ (377,081) $ (191,688,793)